glp 1 effects on brain Dual-action obesity drug rewires circuits for appetite GLP-1 and health: Beyond weight
Description
Dispense a small amount of VOL
Study the signals of amplified dual-incretin coordination
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
It seems that this goal may not be as far-fetched as previously imagined
My GLP-1 Journal: One Healthy Habit at a Time [Lea, Mandy] on Amazon.com
